{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T11:16:27Z","timestamp":1789816587289,"version":"4.0.1"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.transproceed.2026.08.016","type":"journal-article","created":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T04:32:06Z","timestamp":1789619526000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Efficacy and Safety of Paricalcitol Therapy for Kidney Transplantation Recipients: A Systematic Review and Meta-analysis of Randomized Controlled Trials"],"prefix":"10.1016","author":[{"given":"Bo","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bangcai","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuan","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junjie","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.transproceed.2026.08.016_bib0001","doi-asserted-by":"crossref","first-page":"471","DOI":"10.2215\/CJN.05021107","article-title":"Kidney transplantation as primary therapy for end-stage renal disease: a National Kidney Foundation\/Kidney Disease Outcomes Quality Initiative conference","volume":"3","author":"Abecassis","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.transproceed.2026.08.016_bib0002","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1111\/j.1600-6143.2011.03686.x","article-title":"Systematic review: kidney transplantation compared with dialysis in clinically relevant outcomes","volume":"11","author":"Tonelli","year":"2011","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2026.08.016_bib0003","first-page":"363","article-title":"Intake of marine-derived omega-3 polyunsaturated fatty acids, fish, and meat is associated with mortality in renal transplant recipients","volume":"107","author":"Gomes Neto","year":"2018","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.transproceed.2026.08.016_bib0004","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s40265-019-01074-4","article-title":"Management of post-transplant hyperparathyroidism and bone disease","volume":"79","author":"Delos Santos","year":"2019","journal-title":"Drugs"},{"key":"10.1016\/j.transproceed.2026.08.016_bib0005","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1038\/ki.1997.469","article-title":"Disorders of bone and mineral metabolism after renal transplantation","volume":"52","author":"Massari","year":"1997","journal-title":"Kidney Int"},{"key":"10.1016\/j.transproceed.2026.08.016_bib0006","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1111\/ajt.12425","article-title":"Persistent hyperparathyroidism is a major risk factor for fractures in the five years after kidney transplantation","volume":"13","author":"Perrin","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2026.08.016_bib0007","doi-asserted-by":"crossref","first-page":"732","DOI":"10.2215\/CJN.09310819","article-title":"Metabolic disorders with kidney transplant","volume":"15","author":"Cohen","year":"2020","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.transproceed.2026.08.016_bib0008","doi-asserted-by":"crossref","first-page":"391","DOI":"10.2215\/CJN.03000311","article-title":"Efficacy and safety of paricalcitol therapy for chronic kidney disease: a meta-analysis","volume":"7","author":"Cheng","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.transproceed.2026.08.016_bib0009","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1016\/j.clinthera.2019.09.009","article-title":"Use of paricalcitol as adjunctive therapy to renin-angiotensin-aldosterone system inhibition for diabetic nephropathy: a systematic review of the literature","volume":"41","author":"Schuster","year":"2019","journal-title":"Clin Ther"},{"key":"10.1016\/j.transproceed.2026.08.016_bib0010","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1053\/j.ajkd.2005.10.007","article-title":"Paricalcitol capsule for the treatment of secondary hyperparathyroidism in stages 3 and 4 chronic kidney disease","volume":"47","author":"Coyne","year":"2006","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.transproceed.2026.08.016_bib0011","doi-asserted-by":"crossref","first-page":"F526","DOI":"10.1152\/ajprenal.00316.2003","article-title":"1,25-Dihydroxyvitamin D3 decreases podocyte loss and podocyte hypertrophy in the subtotally nephrectomized rat","volume":"286","author":"Kuhlmann","year":"2003","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.transproceed.2026.08.016_bib0012","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1038\/ki.2008.408","article-title":"Suppression of renin-angiotensin gene expression in the kidney by paricalcitol","volume":"74","author":"Freundlich","year":"2008","journal-title":"Kidney Int"},{"key":"10.1016\/j.transproceed.2026.08.016_bib0013","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1681\/ASN.2009080872","article-title":"Vitamin D receptor attenuates renal fibrosis by suppressing the renin-angiotensin system","volume":"21","author":"Zhang","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.transproceed.2026.08.016_bib0014","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1046\/j.1523-1755.2001.0600031131.x","article-title":"Proteinuria as a modifiable risk factor for the progression of non-diabetic renal disease","volume":"60","author":"Jafar","year":"2001","journal-title":"Kidney Int"},{"key":"10.1016\/j.transproceed.2026.08.016_bib0015","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1111\/j.1523-1755.2004.00653.x","article-title":"Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: lessons from RENAAL","volume":"65","author":"de Zeeuw","year":"2004","journal-title":"Kidney Int"},{"key":"10.1016\/j.transproceed.2026.08.016_bib0016","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.1111\/j.1600-6143.2007.02010.x","article-title":"Respective predictive role of urinary albumin excretion and nonalbumin proteinuria on graft loss and death in renal transplant recipients","volume":"7","author":"Halimi","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2026.08.016_bib0017","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1097\/TP.0b013e3181c352c5","article-title":"The clinical significance of early proteinuria after renal transplantation","volume":"89","author":"Cherukuri","year":"2010","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2026.08.016_bib0024","doi-asserted-by":"crossref","first-page":"e49","DOI":"10.1097\/TP.0b013e3182855565","article-title":"Effects of oral paricalcitol on secondary hyperparathyroidism and proteinuria of kidney transplant patients","volume":"95","author":"Gonzalez","year":"2013","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2026.08.016_bib0027","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1097\/TP.0000000000001339","article-title":"Effect of paricalcitol on FGF-23 and Klotho in kidney transplant recipients","volume":"100","author":"Donate-Correa","year":"2016","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2026.08.016_bib0028","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.ekir.2017.08.016","article-title":"Paricalcitol versus calcifediol for treating hyperparathyroidism in kidney transplant recipients","volume":"3","author":"Cruzado","year":"2018","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.transproceed.2026.08.016_bib0021","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ejphar.2013.03.040","article-title":"Magnetic bead-based proteomic technology to study paricalcitol effect in kidney transplant recipients","volume":"709","author":"P\u00e9rez","year":"2013","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.transproceed.2026.08.016_bib0022","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1681\/ASN.2013111185","article-title":"Paricalcitol for secondary hyperparathyroidism in renal transplantation","volume":"26","author":"Trillini","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.transproceed.2026.08.016_bib0023","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1111\/ajt.12227","article-title":"Oral paricalcitol reduces the prevalence of posttransplant hyperparathyroidism: results of an open-label randomized trial","volume":"13","author":"Amer","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2026.08.016_bib0025","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1111\/tri.12973","article-title":"Early introduction of oral paricalcitol in renal transplant recipients: an open-label randomized study","volume":"30","author":"Pihlstr\u00f6m","year":"2017","journal-title":"Transpl Int"},{"key":"10.1016\/j.transproceed.2026.08.016_bib0026","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1111\/tri.13323","article-title":"Paricalcitol versus placebo for reduction of proteinuria in kidney transplant recipients: a double-blind, randomized controlled trial","volume":"31","author":"Oblak","year":"2018","journal-title":"Transpl Int"},{"key":"10.1016\/j.transproceed.2026.08.016_bib0034","doi-asserted-by":"crossref","first-page":"2924","DOI":"10.1016\/j.transproceed.2010.07.077","article-title":"Effect of paricalcitol on the urinary peptidome of kidney transplant patients","volume":"42","author":"P\u00e9rez","year":"2010","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2026.08.016_bib0033","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1186\/s13643-025-02828-w","article-title":"Effects of vitamin D supplements on bone metabolism in kidney transplant recipients: a systematic review and meta-analysis","volume":"14","author":"Cai","year":"2025","journal-title":"Syst Rev"},{"key":"10.1016\/j.transproceed.2026.08.016_bib0029","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1681\/ASN.V981427","article-title":"19-Nor-1-alpha-25-dihydroxyvitamin D2 (paricalcitol) safely and effectively reduces the levels of intact parathyroid hormone in patients on hemodialysis","volume":"9","author":"Martin","year":"1998","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.transproceed.2026.08.016_bib0030","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1186\/1471-2369-14-199","article-title":"Vitamin D supplementation and mortality risk in chronic kidney disease: a meta-analysis of 20 observational studies","volume":"14","author":"Zheng","year":"2013","journal-title":"BMC Nephrol"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134526004409?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134526004409?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T10:51:29Z","timestamp":1789815089000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134526004409"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":29,"alternative-id":["S0041134526004409"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2026.08.016","relation":{},"ISSN":["0041-1345"],"issn-type":[{"value":"0041-1345","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and Safety of Paricalcitol Therapy for Kidney Transplantation Recipients: A Systematic Review and Meta-analysis of Randomized Controlled Trials","name":"articletitle","label":"Article Title"},{"value":"Transplantation Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transproceed.2026.08.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}